Campto 40 mg/2 ml

Campto 40 mg/2 ml is a medicine authorised by Swissmedic under authorisation number 53470. The authorisation holder is Pfizer AG. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 08 May 1998 and the authorisation is limited until 30 September 2026. ATC code L01CE02 places the medicine in the group Antineoplastic agents.

  • Dispensing category A
  • Authorisation number 53470
  • ATC L01CE02
  • Synthetic medicines
Authorisation data
Authorisation number53470
NameCampto 40 mg/2 ml
Full nameCampto 40 mg/2 ml, Konzentrat zur Herstellung einer Infusionslösung
Authorisation holderPfizer AG
Medicinal product codeSynthetic medicines
Dispensing categoryA · Prescription, not repeatable
ATC codeL01CE02
First authorisation08 May 1998
Authorisation validity30 September 2026
Strengths
No.NameDispensing categoryAuthorisation date
1Campto 40 mg/2 ml, Konzentrat zur Herstellung einer InfusionslösungA08 May 1998
2Campto 100 mg/5 ml, Konzentrat zur Herstellung einer InfusionslösungA08 May 1998
3Campto 300 mg/15 ml, Konzentrat zur Herstellung einer InfusionslösungA22 October 2007

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
451Durchstechflasche(n)L01CE0207.16.1.A
471Durchstechflasche(n)L01CE0207.16.1.A
491Durchstechflasche(n)L01CE0207.16.1.A

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Campto 40 mg/2 ml authorised in Switzerland?

Yes. Campto 40 mg/2 ml is authorised by Swissmedic under authorisation number 53470, data as of 01 September 2026. The authorisation is limited until 30 September 2026.

Which dispensing category does Campto 40 mg/2 ml have?

Campto 40 mg/2 ml is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.

Who is the authorisation holder of Campto 40 mg/2 ml?

The authorisation holder is Pfizer AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com